Innovative AI Method Measures and Monitors Aging Cells

A cutting-edge AI-powered technique for measuring and tracking cellular senescence offers new insights into aging and age-related diseases, paving the way for potential therapies.
Recent advancements in high-resolution imaging combined with artificial intelligence (AI) have led to a novel approach for tracking cellular aging and damage. Researchers at NYU Langone Health have developed a machine learning-based tool capable of analyzing changes in cell nuclei, which are indicative of cellular senescence—a state where cells stop dividing and contribute to aging-related diseases such as cancer and heart disease. This AI-assisted technique allows scientists to quantify specific nuclear features, such as size, shape irregularities, and genetic material density, providing a comprehensive senescence score.
The study involved training a computer system using animal cells subjected to chemical stress to simulate aging. The AI identified measurable changes in nuclear morphology that closely correlated with the degree of cell aging. These features include nuclear expansion, denser centers or foci, and irregular shapes, along with lighter-staining genetic material. Validation experiments confirmed that cells with these nuclear characteristics exhibited typical signs of senescence, including halted reproduction and DNA damage.
To facilitate widespread research, the team developed the nuclear morphometric pipeline (NMP), which condenses nuclear features into a single senescence score. This score successfully distinguished between healthy and senescent cells across different age groups and tissue types, from young to aged mice. The NMP also effectively tracked tissue repair processes, identifying senescent cells in injured muscle tissue and distinguishing aged cartilage cells from younger ones, highlighting its potential for studying aging and related diseases.
The researchers plan to expand their work to include human tissues and explore the integration of the NMP with other biomarker tools. Their ultimate goal is to leverage this technology to develop interventions that can prevent or reverse cellular aging, accelerating research on anti-aging therapies. The approach, which relies on commonly used nuclear staining, offers a reliable and accessible alternative to previous, more complex methods for detecting senescent cells. This breakthrough promises to enhance understanding of tissue regeneration, aging processes, and disease progression, paving the way for innovative treatments.
Source: https://medicalxpress.com/news/2025-07-ai-technique-track-aging-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
TMEM63A Gene and Its Role in Brain Myelin Formation in Leukodystrophy
Researchers at Oregon Health & Science University have identified the TMEM63A gene as a key regulator of myelin formation in the brain, offering new insights into rare leukodystrophies and potential treatments for demyelinating diseases like multiple sclerosis.
Autoantibodies in Patients Could Unlock New Strategies to Enhance Cancer Immunotherapy
Emerging research reveals that autoantibodies naturally produced by patients may enhance responses to cancer immunotherapy, offering new pathways to more effective personalized treatments.
Stem Cell Transplant as a Promising Cure for Pediatric Monogenic Inflammatory Bowel Disease
Research shows hematopoietic stem cell transplantation as a promising, potentially curative therapy for children with severe monogenic inflammatory bowel disease, offering new hope for early intervention.
The Role of Education and Social Factors in Rheumatic and Musculoskeletal Diseases
Emerging research emphasizes the critical role of social determinants like income and education in shaping outcomes for patients with rheumatic and musculoskeletal diseases. Findings from the EULAR 2025 congress reveal how these factors influence disease progression and mortality, highlighting the need for targeted interventions to promote health equity.